FRASCA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 6.486
EU - Europa 3.673
AS - Asia 3.442
SA - Sud America 529
AF - Africa 513
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 14.657
Nazione #
US - Stati Uniti d'America 6.231
SG - Singapore 1.675
RU - Federazione Russa 1.118
IT - Italia 983
CN - Cina 982
IE - Irlanda 451
BR - Brasile 430
UA - Ucraina 374
CI - Costa d'Avorio 317
VN - Vietnam 292
CA - Canada 198
DE - Germania 188
FR - Francia 174
KR - Corea 146
GB - Regno Unito 85
IN - India 83
SE - Svezia 77
NG - Nigeria 54
SN - Senegal 48
FI - Finlandia 40
MX - Messico 37
PL - Polonia 36
TR - Turchia 34
AR - Argentina 32
KE - Kenya 31
NL - Olanda 29
BD - Bangladesh 26
JP - Giappone 26
IR - Iran 24
IQ - Iraq 23
ZA - Sudafrica 23
CH - Svizzera 22
HK - Hong Kong 21
UZ - Uzbekistan 21
ES - Italia 20
EC - Ecuador 18
CZ - Repubblica Ceca 17
ID - Indonesia 17
BJ - Benin 14
VE - Venezuela 13
CO - Colombia 12
BE - Belgio 10
CL - Cile 9
SA - Arabia Saudita 9
PY - Paraguay 8
AU - Australia 7
AZ - Azerbaigian 7
GR - Grecia 7
MA - Marocco 7
PK - Pakistan 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
RO - Romania 6
AT - Austria 5
BG - Bulgaria 5
EU - Europa 5
HR - Croazia 5
JM - Giamaica 5
LB - Libano 5
PE - Perù 5
PH - Filippine 5
AL - Albania 4
DZ - Algeria 4
KZ - Kazakistan 4
MY - Malesia 4
PS - Palestinian Territory 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
EG - Egitto 3
IL - Israele 3
LU - Lussemburgo 3
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
GE - Georgia 2
JO - Giordania 2
KG - Kirghizistan 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
RS - Serbia 2
SV - El Salvador 2
TW - Taiwan 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
Totale 14.653
Città #
Singapore 1.004
Dallas 891
Santa Clara 746
Chandler 491
Moscow 485
Dublin 450
San Jose 418
Chicago 407
Jacksonville 391
Ashburn 344
Abidjan 317
Houston 251
Hefei 219
Boardman 203
Catania 200
Los Angeles 165
Civitanova Marche 164
Seoul 145
Beijing 142
Lauterbourg 137
Quintano 129
Nanjing 128
Cambridge 122
Lawrence 121
Andover 119
Toronto 117
Ho Chi Minh City 89
Grafing 79
Council Bluffs 71
Wilmington 71
Hanoi 70
New York 62
San Mateo 62
Des Moines 59
Buffalo 50
Dakar 48
São Paulo 47
Nanchang 44
Bremen 39
Palermo 39
Hebei 34
Jiaxing 31
Munich 30
Saint Petersburg 29
Shenyang 29
Ottawa 28
Lagos 27
Montreal 27
The Dalles 27
Bari 26
Orem 26
Warsaw 26
Columbus 25
Tokyo 25
Changsha 24
Kochi 24
Abuja 23
Milan 23
Tianjin 23
Lappeenranta 22
San Francisco 22
Stockholm 22
Amsterdam 20
Atlanta 20
Brooklyn 18
Ardabil 16
Denver 16
Hong Kong 16
London 16
Rio de Janeiro 16
Manchester 15
Cotonou 14
Johannesburg 14
Brno 13
Haiphong 13
Rome 13
Chennai 12
Frankfurt am Main 12
Phoenix 12
Pozzallo 12
Seattle 12
Augusta 11
Belpasso 11
Dong Ket 11
Helsinki 11
Poplar 11
Pune 11
San Valentino Torio 11
Washington 11
Ankara 10
Brussels 10
Da Nang 10
Mascalucia 10
Mexico City 10
Nairobi 10
Redondo Beach 10
Biên Hòa 9
Curitiba 9
Leawood 9
Paternò 9
Totale 10.183
Nome #
Peroxisomal proliferator-activated receptor-γ agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells 353
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 209
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 205
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 193
17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells 187
c-Abl and insulin receptor signalling 169
Different FT3/TSH correlation in acquired and congenital hypothyroid patients reveals a different hypothalamic set-point 167
Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid 157
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels 154
Different Effects of the Insulin Receptor Isoforms on 32D Cell Growth and Differentiation 153
BRAF(V600E) mutation and the biology of papillary thyroid cancer 149
Curcumin, hormesis and the nervous system 149
Abnormal 1-hour post-load glycemia during pregnancy impairs post-partum metabolic status: a single-center experience 148
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 146
Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism 146
Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells 144
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 143
Challenges in the treatment of parathyroid carcinoma: a case report 143
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 142
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 141
Early Massive Fibrosis of a Single Extraocular Muscle Causing Severe Unilateral Euthyroid Graves' Ophthalmopathy in a Patient with Hypercholesterolemia Who Smokes 136
Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study 136
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 135
Early detection of suspicious lymph nodes in differentiated thyroid cancer 133
Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression 130
ROLE OF BRAF(V600) MUTATION IN THE RESISTANCE TO GEFITINIB OF THYROID CANCER CELLS 129
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 125
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes 124
BRAF T1799A Mutation in Thyroid Cancer Predicts Progressive disease 124
Updates on the management of advanced, metastatic, and radioiodine refractory differentiated thyroid cancer 123
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 122
Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease 122
DeltaNp73alfa favors thyroid tumor progression by PTEN tumor suppressor downregulation 120
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 120
Clinical Assessment of Altered Eating Behaviors in People with Obesity Using the EBA-O Questionnaire 119
Consider or not consider: the unsolved question on the use of radioactive iodine for differentiated thyroid cancer with low to intermediate risk of recurrence 118
Surveillance of patients with differentiated thyroid cancer and indeterminate response: a longitudinal study on basal thyroglobulin trend 118
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 117
Effect of gluten-free diet on autoimmune thyroiditis progression in patients with no symptoms or histology of celiac disease: a meta-analysis 117
Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves' Ophthalmopathy to Parenteral Corticosteroids 114
Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway 113
Insulin receptor isoforms in physiology and disease: An updated view 113
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved 109
Worldwide increasing incidence of thyroid cancer:update on epidemiology and risk factors 109
TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 108
Clinical management of indeterminate thyroid nodules needs to be revisited. New evidence for a personalized approach to the problem 107
DeltaNp73alfa increases Akt phosphorylation in thyroid cancer cells: role of PTEN tumor suppressor 104
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 103
Therapeutic efficacy and patient compliance of levothyroxine liquid and softgel formulations taken with meals: a systematic review 102
Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review 102
p73 tumor-suppressor activity is impaired in human thyroid cancer 98
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 97
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 97
The possible role of cancer stem cells in the resistance to kinase inhibitors of advanced thyroid cancer 97
Nuove strategie di indagine delle linfoadenopatie nel carcinoma tiroideo 96
Endocrinopatie e anemie / anemie ed endocrinopatie: una si(pali)ndrome spesso misconosciuta 96
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 96
Selenium exerts protective effects against oxidative stress and cell damage in human thyrocytes and fibroblasts 96
The SGLT-1/SGLT-2 dual inhibitor canagliflozin has positive effects on glucose trends, targets and variability in late dumping syndrome following gastrectomy: A case report 95
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome 95
Papillary thyroid cancer incidence in the volcanic area of Sicily 95
p53 family proteins in thyroid cancer 94
The p53-homologue p63 may promote thyroid cancer progression 94
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease 94
Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer 93
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 93
Seasonal Variations in TSH Serum Levels in Athyreotic Patients under L-Thyroxine Replacement Monotherapy. 93
Thyroid Cancer and Circadian Clock Disruption 93
Associazione tra la sindrome metabolica e le caratteristiche clinico-patologiche del carcinoma papillifero tiroideo 93
Isolation and characteriziation of cancer thyrospheres 92
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism 92
Lymph Node Ratio as a Predictive Factor of Persistent/Recurrent Disease in Patients With Medullary Thyroid Cancer: A Single-Center Retrospective Study 91
Il BRAF (V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al gefinitib. 91
The isoform A of the insulin receptor as a regulator of the IGF system 91
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 90
Cytological diagnosis difficulties in hyalinizing trabecular adenoma of the thyroid 89
Impact of post-operative radioiodine remnant abalation in differentiated thyroid cancer according to risk categories. 89
Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling 89
EXOME WIDE ANALYSIS IN 5 PAPILLARY THYROID CARCINOMAS 88
Thyroid cancer cell resistance to gefinitib depends on the constitutive oncogenic activation of the ERK pahway 88
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 87
HMGA1 inhibits the function of p53 family members in thyroid cancer cells 87
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells 87
Prevalence and significance of indeterminate calcitonin values in patients with thyroid nodules: A systematic review and meta-analysis 85
Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center 85
Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells 85
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years 85
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 85
TAp63alfa antagonizes p53 oncosuppressor function in thyroid cancer cells 84
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 84
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity 84
The role of insulin receptor isoform a (IR-A) in cancer 84
Thyrospheres: a new in vitro model for testing human thyroid endocrine disruptors 83
Le cellule staminali tiroidee, isolate da gozzi di soggetti adulti, crescono in aggregati sferici in risposta a stimolazione con fattori di crescita e necessitano del TSH per differenziare in Tireociti maturi 83
In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription 82
GENOME WIDE ANALYSIS IN PAPILLARY THYROID CARCINOMA 82
Agonisti del recettore del GLP1 e infiammazione: non solo compenso glicemico 82
Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity 81
Tap73alfa Increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 81
Obesity, insulin-resistance and cancer 81
Totale 11.422
Categoria #
all - tutte 46.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021151 0 0 0 0 0 0 0 0 0 0 127 24
2021/2022879 107 128 6 11 127 9 134 34 81 3 27 212
2022/20231.700 129 46 31 316 150 278 2 264 388 21 46 29
2023/2024829 40 128 33 58 41 153 41 63 6 20 111 135
2024/20253.135 40 615 154 266 629 336 60 93 190 273 237 242
2025/20266.428 403 393 1.130 481 1.019 1.329 736 145 338 378 76 0
Totale 14.890